|
| Status |
Public on Dec 22, 2016 |
| Title |
caArray_willm-00090: Gene Expression Profiling Reveals Novel Genes for Improved Risk Classification and Outcome Prediction in Pediatric Acute Lymphoblastic Leukemia: Identification, Cloning, and Validation of OPAL1 |
| Organism |
Homo sapiens |
| Experiment type |
Expression profiling by array
|
| Summary |
Affymetrix HG_U95Av2 oligonucleotide microarrays were used to perform gene expression profiling of 254 cases of pediatric ALL in order to determine genes predictive of outcome that may be useful in refining risk classification.
|
| |
|
| Overall design |
willm-00090
Assay Type: Gene Expression
Provider: Affymetrix
Array Designs: HG_U95Av2
Organism: Homo sapiens (ncbitax)
Material Types: synthetic_DNA, synthetic_RNA, organism_part, whole_organism
Disease States: Pre-treatment leukemia diagnostic sample
|
| |
|
| Citation missing |
Has this study been published? Please login to update or notify GEO. |
| Submission date |
Dec 21, 2016 |
| Last update date |
Dec 13, 2018 |
| Contact name |
Mervi Heiskanen |
| E-mail(s) |
mervi.heiskanen@nih.gov
|
| Phone |
2402765175
|
| Organization name |
NCI
|
| Department |
CBIIT
|
| Street address |
9609 Medical Center Drive, 1W378
|
| City |
Rockville |
| State/province |
MD |
| ZIP/Postal code |
20850 |
| Country |
USA |
| |
|
| Platforms (1) |
| GPL8300 |
[HG_U95Av2] Affymetrix Human Genome U95 Version 2 Array |
|
| Samples (254)
|
|
| Relations |
| BioProject |
PRJNA358405 |
Less...
More...